Stay updated on Immunotherapy Combinations in Gastric Cancers Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Gastric Cancers Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Gastric Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe MORPHEUS study page now shows a 403 Forbidden error instead of the study details, effectively restricting access to the trial information and related navigation on ClinicalTrials.gov.SummaryDifference24%

- Check36 days agoChange DetectedThe page metadata now includes the NIH grant/contract year 2016. The documentation revision has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check57 days agoChange DetectedThe Morpheus-Gastric and Esophageal Cancer trial is terminated with results posted and 219 participants enrolled; new sites in Seoul National University Hospital and National Taiwan University Hospital in Taipei are now listed.SummaryDifference2%

- Check72 days agoChange DetectedRevision: v3.6.4 replaces the previous revision tag on the page, signaling a minor update to the page version metadata. It does not modify study details, eligibility criteria, or user-facing functionality.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision: v3.6.3 has been added, replacing the previous Revision: v3.6.2. This indicates a version update of the page template or CMS without altering the underlying study details.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page revision number was updated to v3.6.2, reflecting maintenance/UI updates without changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy Combinations in Gastric Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Gastric Cancers Clinical Trial page.